Edmond De Rothschild Holding S.A. Gilead Sciences, Inc. Transaction History

Edmond De Rothschild Holding S.A.

$5.87 Billion
Q1 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 221,682 shares of GILD stock, worth $15.2 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

221,682

Previous 223,543 0.83%

Holding current value

$15.2 Million

Previous $18.1 Million 10.33%

% of portfolio

0.28%

Previous 0.33%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $133,210 - $162,446	-1,861 Reduced 0.83%	221,682 $16.2 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $32,824 - $37,224	-448 Reduced 0.2%	223,543 $18.1 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.72 Million - $1.88 Million	23,322 Added 11.62%	223,991 $16.8 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $15.6 Million - $17.8 Million	-202,244 Reduced 50.2%	200,669 $16.6 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $3.18 Million - $4.56 Million	-50,970 Reduced 11.23%	402,913 $34.6 Million

Q3 2022 Nov 09, 2022	SELL	$59.54 - $68.01 $1.06 Million - $1.21 Million	-17,779 Reduced 3.77%	453,883 $28 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.69 Million - $3.03 Million	-46,679 Reduced 9.01%	471,662 $29.2 Million
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $1.14 Million - $1.43 Million	-19,683 Reduced 3.66%	518,341 $30.8 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $8.87 Million - $10.1 Million	-136,753 Reduced 20.27%	538,024 $39.1 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $2.77 Million - $2.99 Million	-40,988 Reduced 5.73%	674,777 $47.1 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $5.09 Million - $5.56 Million	80,215 Added 12.62%	715,765 $49.3 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $1.62 Million - $1.84 Million	26,942 Added 4.43%	635,550 $41.1 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $636,462 - $725,219	-11,235 Reduced 1.81%	608,608 $35.5 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $299,446 - $376,501	4,822 Added 0.78%	619,843 $39.2 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $193,871 - $225,120	-2,680 Reduced 0.43%	615,021 $47.3 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $16.1 Million - $20.6 Million	-256,658 Reduced 29.35%	617,701 $46.2 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $5.45 Million - $5.99 Million	-88,389 Reduced 9.18%	874,359 $56.8 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $4.82 Million - $5.32 Million	-77,172 Reduced 7.42%	962,748 $61 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $3.27 Million - $3.67 Million	-52,847 Reduced 4.84%	1,039,920 $70.3 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $1.89 Million - $2.11 Million	30,153 Added 2.84%	1,092,767 $71 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $3.41 Million - $4.45 Million	56,382 Added 5.6%	1,062,614 $66.5 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $7.85 Million - $8.69 Million	-110,133 Reduced 9.87%	1,006,232 $77.7 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $253,745 - $295,984	3,911 Added 0.35%	1,116,365 $79.1 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $10 Million - $12.2 Million	-137,739 Reduced 11.02%	1,112,454 $83.9 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $8.66 Million - $10.2 Million	-121,659 Reduced 8.87%	1,250,193 $89.6 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $98.9 Million - $117 Million	1,371,852	1,371,852 $111 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Account

Edmond De Rothschild Holding S.A. Gilead Sciences, Inc. Transaction History